
The global API of Sartan Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Sartan drugs are the latest generation of antihypertensive drugs. They have good blood pressure lowering effects and drug tolerance, fewer adverse reactions, and have a protective effect on target organs. They are widely used in clinical applications. There are more than 1 billion people suffering from hypertension worldwide, and long-term treatment has boosted the demand for Sartan APIs and intermediates. In 2022 ,production of Sartan API from Zhejiang Huahai Pharmaceutical is 2701.40 ton.
This report aims to provide a comprehensive presentation of the global market for API of Sartan Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding API of Sartan Drugs.
Report Scope
The API of Sartan Drugs market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global API of Sartan Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the API of Sartan Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy’s Laboratories
Verdant Pharma Pvt Ltd
Anuh Pharma Ltd.
Ningbo Menovo Pharmaceutical
Tianyu Pharmaceutical
Zhejiang Huahai Pharmaceutical
Changzhou Kony Pharmaceutical
Zhejiang Kinglyuan Pharmaceutical
Zhejiang Xinsaike Pharmaceutical
Rundu Pharma
Teva
Mylan Laboratories
Changzhou Siyao
Novartis
Novartis
Novartis
EUROAPI
Hengrui Medicine
Segment by Type
Losartan API
Valsartan API
Irbesartan API
Olmesartan API
Candesartan API
Telmisartan API
Segment by Application
Tablets
Capsules
Others
Production by Region
North America
Europe
China
Japan
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of API of Sartan Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of API of Sartan Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of API of Sartan Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 API of Sartan Drugs Market Overview
1.1 Product Definition
1.2 API of Sartan Drugs Segment by Type
1.2.1 Global API of Sartan Drugs Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Losartan API
1.2.3 Valsartan API
1.2.4 Irbesartan API
1.2.5 Olmesartan API
1.2.6 Candesartan API
1.2.7 Telmisartan API
1.3 API of Sartan Drugs Segment by Application
1.3.1 Global API of Sartan Drugs Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global API of Sartan Drugs Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global API of Sartan Drugs Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global API of Sartan Drugs Production Estimates and Forecasts (2019-2030)
1.4.4 Global API of Sartan Drugs Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global API of Sartan Drugs Production Market Share by Manufacturers (2019-2024)
2.2 Global API of Sartan Drugs Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of API of Sartan Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global API of Sartan Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global API of Sartan Drugs Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of API of Sartan Drugs, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of API of Sartan Drugs, Product Offered and Application
2.8 Global Key Manufacturers of API of Sartan Drugs, Date of Enter into This Industry
2.9 API of Sartan Drugs Market Competitive Situation and Trends
2.9.1 API of Sartan Drugs Market Concentration Rate
2.9.2 Global 5 and 10 Largest API of Sartan Drugs Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 API of Sartan Drugs Production by Region
3.1 Global API of Sartan Drugs Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global API of Sartan Drugs Production Value by Region (2019-2030)
3.2.1 Global API of Sartan Drugs Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of API of Sartan Drugs by Region (2025-2030)
3.3 Global API of Sartan Drugs Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global API of Sartan Drugs Production by Region (2019-2030)
3.4.1 Global API of Sartan Drugs Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of API of Sartan Drugs by Region (2025-2030)
3.5 Global API of Sartan Drugs Market Price Analysis by Region (2019-2024)
3.6 Global API of Sartan Drugs Production and Value, Year-over-Year Growth
3.6.1 North America API of Sartan Drugs Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe API of Sartan Drugs Production Value Estimates and Forecasts (2019-2030)
3.6.3 China API of Sartan Drugs Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan API of Sartan Drugs Production Value Estimates and Forecasts (2019-2030)
3.6.5 India API of Sartan Drugs Production Value Estimates and Forecasts (2019-2030)
4 API of Sartan Drugs Consumption by Region
4.1 Global API of Sartan Drugs Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global API of Sartan Drugs Consumption by Region (2019-2030)
4.2.1 Global API of Sartan Drugs Consumption by Region (2019-2024)
4.2.2 Global API of Sartan Drugs Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America API of Sartan Drugs Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America API of Sartan Drugs Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe API of Sartan Drugs Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe API of Sartan Drugs Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific API of Sartan Drugs Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific API of Sartan Drugs Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa API of Sartan Drugs Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa API of Sartan Drugs Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global API of Sartan Drugs Production by Type (2019-2030)
5.1.1 Global API of Sartan Drugs Production by Type (2019-2024)
5.1.2 Global API of Sartan Drugs Production by Type (2025-2030)
5.1.3 Global API of Sartan Drugs Production Market Share by Type (2019-2030)
5.2 Global API of Sartan Drugs Production Value by Type (2019-2030)
5.2.1 Global API of Sartan Drugs Production Value by Type (2019-2024)
5.2.2 Global API of Sartan Drugs Production Value by Type (2025-2030)
5.2.3 Global API of Sartan Drugs Production Value Market Share by Type (2019-2030)
5.3 Global API of Sartan Drugs Price by Type (2019-2030)
6 Segment by Application
6.1 Global API of Sartan Drugs Production by Application (2019-2030)
6.1.1 Global API of Sartan Drugs Production by Application (2019-2024)
6.1.2 Global API of Sartan Drugs Production by Application (2025-2030)
6.1.3 Global API of Sartan Drugs Production Market Share by Application (2019-2030)
6.2 Global API of Sartan Drugs Production Value by Application (2019-2030)
6.2.1 Global API of Sartan Drugs Production Value by Application (2019-2024)
6.2.2 Global API of Sartan Drugs Production Value by Application (2025-2030)
6.2.3 Global API of Sartan Drugs Production Value Market Share by Application (2019-2030)
6.3 Global API of Sartan Drugs Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Dr. Reddy’s Laboratories
7.1.1 Dr. Reddy’s Laboratories API of Sartan Drugs Corporation Information
7.1.2 Dr. Reddy’s Laboratories API of Sartan Drugs Product Portfolio
7.1.3 Dr. Reddy’s Laboratories API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Dr. Reddy’s Laboratories Main Business and Markets Served
7.1.5 Dr. Reddy’s Laboratories Recent Developments/Updates
7.2 Verdant Pharma Pvt Ltd
7.2.1 Verdant Pharma Pvt Ltd API of Sartan Drugs Corporation Information
7.2.2 Verdant Pharma Pvt Ltd API of Sartan Drugs Product Portfolio
7.2.3 Verdant Pharma Pvt Ltd API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Verdant Pharma Pvt Ltd Main Business and Markets Served
7.2.5 Verdant Pharma Pvt Ltd Recent Developments/Updates
7.3 Anuh Pharma Ltd.
7.3.1 Anuh Pharma Ltd. API of Sartan Drugs Corporation Information
7.3.2 Anuh Pharma Ltd. API of Sartan Drugs Product Portfolio
7.3.3 Anuh Pharma Ltd. API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Anuh Pharma Ltd. Main Business and Markets Served
7.3.5 Anuh Pharma Ltd. Recent Developments/Updates
7.4 Ningbo Menovo Pharmaceutical
7.4.1 Ningbo Menovo Pharmaceutical API of Sartan Drugs Corporation Information
7.4.2 Ningbo Menovo Pharmaceutical API of Sartan Drugs Product Portfolio
7.4.3 Ningbo Menovo Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Ningbo Menovo Pharmaceutical Main Business and Markets Served
7.4.5 Ningbo Menovo Pharmaceutical Recent Developments/Updates
7.5 Tianyu Pharmaceutical
7.5.1 Tianyu Pharmaceutical API of Sartan Drugs Corporation Information
7.5.2 Tianyu Pharmaceutical API of Sartan Drugs Product Portfolio
7.5.3 Tianyu Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Tianyu Pharmaceutical Main Business and Markets Served
7.5.5 Tianyu Pharmaceutical Recent Developments/Updates
7.6 Zhejiang Huahai Pharmaceutical
7.6.1 Zhejiang Huahai Pharmaceutical API of Sartan Drugs Corporation Information
7.6.2 Zhejiang Huahai Pharmaceutical API of Sartan Drugs Product Portfolio
7.6.3 Zhejiang Huahai Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Zhejiang Huahai Pharmaceutical Main Business and Markets Served
7.6.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7.7 Changzhou Kony Pharmaceutical
7.7.1 Changzhou Kony Pharmaceutical API of Sartan Drugs Corporation Information
7.7.2 Changzhou Kony Pharmaceutical API of Sartan Drugs Product Portfolio
7.7.3 Changzhou Kony Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Changzhou Kony Pharmaceutical Main Business and Markets Served
7.7.5 Changzhou Kony Pharmaceutical Recent Developments/Updates
7.8 Zhejiang Kinglyuan Pharmaceutical
7.8.1 Zhejiang Kinglyuan Pharmaceutical API of Sartan Drugs Corporation Information
7.8.2 Zhejiang Kinglyuan Pharmaceutical API of Sartan Drugs Product Portfolio
7.8.3 Zhejiang Kinglyuan Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Zhejiang Kinglyuan Pharmaceutical Main Business and Markets Served
7.7.5 Zhejiang Kinglyuan Pharmaceutical Recent Developments/Updates
7.9 Zhejiang Xinsaike Pharmaceutical
7.9.1 Zhejiang Xinsaike Pharmaceutical API of Sartan Drugs Corporation Information
7.9.2 Zhejiang Xinsaike Pharmaceutical API of Sartan Drugs Product Portfolio
7.9.3 Zhejiang Xinsaike Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Zhejiang Xinsaike Pharmaceutical Main Business and Markets Served
7.9.5 Zhejiang Xinsaike Pharmaceutical Recent Developments/Updates
7.10 Rundu Pharma
7.10.1 Rundu Pharma API of Sartan Drugs Corporation Information
7.10.2 Rundu Pharma API of Sartan Drugs Product Portfolio
7.10.3 Rundu Pharma API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Rundu Pharma Main Business and Markets Served
7.10.5 Rundu Pharma Recent Developments/Updates
7.11 Teva
7.11.1 Teva API of Sartan Drugs Corporation Information
7.11.2 Teva API of Sartan Drugs Product Portfolio
7.11.3 Teva API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Teva Main Business and Markets Served
7.11.5 Teva Recent Developments/Updates
7.12 Mylan Laboratories
7.12.1 Mylan Laboratories API of Sartan Drugs Corporation Information
7.12.2 Mylan Laboratories API of Sartan Drugs Product Portfolio
7.12.3 Mylan Laboratories API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Mylan Laboratories Main Business and Markets Served
7.12.5 Mylan Laboratories Recent Developments/Updates
7.13 Changzhou Siyao
7.13.1 Changzhou Siyao API of Sartan Drugs Corporation Information
7.13.2 Changzhou Siyao API of Sartan Drugs Product Portfolio
7.13.3 Changzhou Siyao API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Changzhou Siyao Main Business and Markets Served
7.13.5 Changzhou Siyao Recent Developments/Updates
7.14 Novartis
7.14.1 Novartis API of Sartan Drugs Corporation Information
7.14.2 Novartis API of Sartan Drugs Product Portfolio
7.14.3 Novartis API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Novartis Main Business and Markets Served
7.14.5 Novartis Recent Developments/Updates
7.15 Novartis
7.15.1 Novartis API of Sartan Drugs Corporation Information
7.15.2 Novartis API of Sartan Drugs Product Portfolio
7.15.3 Novartis API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Novartis Main Business and Markets Served
7.15.5 Novartis Recent Developments/Updates
7.16 Novartis
7.16.1 Novartis API of Sartan Drugs Corporation Information
7.16.2 Novartis API of Sartan Drugs Product Portfolio
7.16.3 Novartis API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Novartis Main Business and Markets Served
7.16.5 Novartis Recent Developments/Updates
7.17 EUROAPI
7.17.1 EUROAPI API of Sartan Drugs Corporation Information
7.17.2 EUROAPI API of Sartan Drugs Product Portfolio
7.17.3 EUROAPI API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.17.4 EUROAPI Main Business and Markets Served
7.17.5 EUROAPI Recent Developments/Updates
7.18 Hengrui Medicine
7.18.1 Hengrui Medicine API of Sartan Drugs Corporation Information
7.18.2 Hengrui Medicine API of Sartan Drugs Product Portfolio
7.18.3 Hengrui Medicine API of Sartan Drugs Production, Value, Price and Gross Margin (2019-2024)
7.18.4 Hengrui Medicine Main Business and Markets Served
7.18.5 Hengrui Medicine Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 API of Sartan Drugs Industry Chain Analysis
8.2 API of Sartan Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 API of Sartan Drugs Production Mode & Process
8.4 API of Sartan Drugs Sales and Marketing
8.4.1 API of Sartan Drugs Sales Channels
8.4.2 API of Sartan Drugs Distributors
8.5 API of Sartan Drugs Customers
9 API of Sartan Drugs Market Dynamics
9.1 API of Sartan Drugs Industry Trends
9.2 API of Sartan Drugs Market Drivers
9.3 API of Sartan Drugs Market Challenges
9.4 API of Sartan Drugs Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Dr. Reddy’s Laboratories
Verdant Pharma Pvt Ltd
Anuh Pharma Ltd.
Ningbo Menovo Pharmaceutical
Tianyu Pharmaceutical
Zhejiang Huahai Pharmaceutical
Changzhou Kony Pharmaceutical
Zhejiang Kinglyuan Pharmaceutical
Zhejiang Xinsaike Pharmaceutical
Rundu Pharma
Teva
Mylan Laboratories
Changzhou Siyao
Novartis
Novartis
Novartis
EUROAPI
Hengrui Medicine
Ìý
Ìý
*If Applicable.
